1 |
Aldouri M: The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients. Pathophysiol Haemost Thromb 32: 41, 2002
DOI
ScienceOn
|
2 |
O'Connell NM, Perry DJ, Hodgson AJ, O'Shaughnessy DF, Laffan MA, Smith OP: Recombinant FVIIa in the management of uncontrolled hemorrhage. Transfusion 43: 1711, 2003
DOI
ScienceOn
|
3 |
Hunault M, Bauer KA: Recombinant factor VIIa for the treatment of congenital factor VII deficiency. Semin Thromb Hemost 26: 401, 2000
DOI
PUBMED
ScienceOn
|
4 |
Tcheng WY, Donkin J, Konzal S, Wong WY: Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency. Haemophilia 10: 295, 2004
DOI
ScienceOn
|
5 |
Lanigan DT: Vascular complications associated with orthognathic surgery. Oral Maxillofac Surg Clin North Am 9: 231, 1997
|
6 |
Ragni MV, Lewis JH, Spero JA, Hasiba U: Factor VII deficiency. Am J Hematol 10: 79, 1981
DOI
ScienceOn
|
7 |
Grounds M: Recombinant factor VIIa(rFVIIa) and its use in severe bleeding in surgery and trauma: a review. Blood Rev 17: S11, 2003
DOI
PUBMED
ScienceOn
|
8 |
Mariani G, Herrmann FH, Dolce A, Batorova A, Etro D, Peyvandi F, Wulff K, Schved JF, Auerswald G, Ingerslev J, Bernardi F; International factor VII Deficiency study Group: Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thromb Haemost 93: 481, 2005
|